Vineet K. Dhiman

ORCID: 0000-0002-6867-5034
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer, Lipids, and Metabolism
  • Folate and B Vitamins Research
  • Epigenetics and DNA Methylation
  • Cancer-related gene regulation
  • RNA modifications and cancer
  • Prostate Cancer Treatment and Research
  • RNA Research and Splicing
  • Genomics and Chromatin Dynamics
  • GDF15 and Related Biomarkers
  • Monoclonal and Polyclonal Antibodies Research
  • Estrogen and related hormone effects
  • Cancer-related molecular mechanisms research
  • RNA and protein synthesis mechanisms
  • PI3K/AKT/mTOR signaling in cancer
  • Histone Deacetylase Inhibitors Research
  • Receptor Mechanisms and Signaling
  • Polyamine Metabolism and Applications

Roswell Park Comprehensive Cancer Center
2011-2021

Cancer Genetics (United States)
2011-2021

University of Chicago
2017-2020

Argonne National Laboratory
2017

University at Buffalo, State University of New York
2011

Abstract ENCODE comprises thousands of functional genomics datasets, and the encyclopedia covers hundreds cell types, providing a universal annotation for genome interpretation. However, particular applications, it may be advantageous to use customized annotation. Here, we develop such custom by leveraging advanced assays, as eCLIP, Hi-C, whole-genome STARR-seq on number data-rich types. A key aspect this is comprehensive experimentally derived networks both transcription factors RNA-binding...

10.1038/s41467-020-14743-w article EN cc-by Nature Communications 2020-07-29

Genome-wide quantification of enhancer activity in the human genome has proven to be a challenging problem. Recent efforts have led development powerful tools for quantification. However, because size and complexity, these yet applied whole genome. In current study, we use prostate cancer cell line, LNCaP as model perform STARR-seq (WHG-STARR-seq) reliably obtain an assessment activity. This approach builds upon previously developed fly CapSTARR-seq techniques targeted genomic regions. With...

10.1186/s13059-017-1345-5 article EN cc-by Genome biology 2017-11-15

The current study investigated transcriptional distortion in prostate cancer cells using the vitamin D receptor (VDR) as a tool to examine how epigenetic events driven by corepressor binding and CpG methylation lead aberrant gene expression. These relationships were non-malignant RWPE-1 that 1α,25(OH) 2 3 responsive (RWPE-1) malignant cell lines partially (RWPE-2) resistant (PC-3). studies revealed selective attenuation repression of VDR responses reflected their loss antiproliferative...

10.1093/carcin/bgs331 article EN Carcinogenesis 2012-10-20

Dietary folate is essential in all tissues to maintain several metabolite pools and cellular proliferation. Prostate cells, due specific metabolic characteristics, have increased demand support proliferation prevent genetic epigenetic damage. Although studies found that dietary interventions can affect colon cancer biology rodent models, its impact on prostate unknown. The purpose of this study was determine whether manipulation, possibly being primary importance for epithelial cell...

10.1158/1940-6207.capr-11-0140 article EN Cancer Prevention Research 2011-08-12

// Vineet K. Dhiman 1 , Kristopher Attwood 2 Moray J. Campbell 3 and Dominic Smiraglia Department of Cancer Genetics, Roswell Park Institute, Buffalo, NY, USA Biostatistics Bioinformatics, Pharmacology Therapeutics, Correspondence to: Smiraglia, email: Keywords : DNA methylation, androgen receptor, gene transcription, nuclear regulated target genes, Chromosome Section Received November 23, 2015 Accepted 24, Published December 04, Abstract methylation is an epigenetic modification that...

10.18632/oncotarget.6471 article EN Oncotarget 2015-12-04

Germline KLLN promoter hypermethylation was recently identified as a potential genetic etiology of the cancer predisposition syndrome, Cowden syndrome (CS), when no causal PTEN gene mutation found. We screened for methylation in large prospective series CS patients and determined risk benign malignant features with increased both without mutation/variant unknown significance. In all, 1012 meeting relaxed International Consortium criteria including 261 mutation-positive patients, 187...

10.1038/ejhg.2015.8 article EN cc-by-nc-nd European Journal of Human Genetics 2015-02-11

Abstract ENCODE comprises thousands of functional genomics datasets, and the encyclopedia covers hundreds cell types, providing a universal annotation for genome interpretation. However, particular applications, it may be advantageous to use customized annotation. Here, we develop such custom by leveraging advanced assays, as eCLIP, Hi-C, whole-genome STARR-seq on number data-rich types. A key aspect this is comprehensive experimentally derived networks both transcription factors RNA-binding...

10.1101/706424 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2019-07-18

Understanding the epigenetic control of normal differentiation programs might yield principal information about critical regulatory states that are disturbed in cancer. We utilized established non-malignant HPr1-AR prostate epithelial cell model upon androgen exposure commits to a luminal trajectory from basal-like state. profile dynamic transcriptome associated with this transition at multiple time points (0 h, 1 24 96 h), and confirm expression patterns strongly indicative progressive...

10.1038/s41598-021-91037-1 article EN cc-by Scientific Reports 2021-06-01

Abstract The archetypical co-repressors NCOR1 and NCOR2/SMRT exist in large complexes with histone deacetylases significantly control multiple transcription factors (TFs), including nuclear receptors such as the VDR AR. are altered cancer by mechanisms, mutation, but it remains unclear how this disrupts their unique shared functions either to commission or decommission enhancers through genome. Previously, we established that co-repressor recruitment prostate (CaP) induces sustained targeted...

10.1158/1538-7445.am2014-1383 article EN Cancer Research 2014-10-01
Coming Soon ...